128 related articles for article (PubMed ID: 20712779)
1. Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.
Hider RC; Silva AM; Podinovskaia M; Ma Y
Ann N Y Acad Sci; 2010 Aug; 1202():94-9. PubMed ID: 20712779
[TBL] [Abstract][Full Text] [Related]
2. Non-transferrin-bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis.
Matinaho S; Parkkinen J
Transfusion; 2005 Jun; 45(6):927-33. PubMed ID: 15934991
[TBL] [Abstract][Full Text] [Related]
3. Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation.
Silva AM; Hider RC
Biochim Biophys Acta; 2009 Oct; 1794(10):1449-58. PubMed ID: 19505594
[TBL] [Abstract][Full Text] [Related]
4. Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy.
Kim CM; Park RY; Choi MH; Sun HY; Shin SH
J Infect Dis; 2007 Jan; 195(1):90-8. PubMed ID: 17152012
[TBL] [Abstract][Full Text] [Related]
5. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
6. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL
J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675
[TBL] [Abstract][Full Text] [Related]
7. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
[TBL] [Abstract][Full Text] [Related]
8. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells.
Parkes JG; Hussain RA; Olivieri NF; Templeton DM
J Lab Clin Med; 1993 Jul; 122(1):36-47. PubMed ID: 8320489
[TBL] [Abstract][Full Text] [Related]
9. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
Breuer W; Ghoti H; Shattat A; Goldfarb A; Koren A; Levin C; Rachmilewitz E; Cabantchik ZI
Am J Hematol; 2012 Jan; 87(1):55-61. PubMed ID: 22125177
[TBL] [Abstract][Full Text] [Related]
10. A novel method for non-transferrin-bound iron quantification by chelatable fluorescent beads based on flow cytometry.
Ma Y; Podinovskaia M; Evans PJ; Emma G; Schaible UE; Porter J; Hider RC
Biochem J; 2014 Nov; 463(3):351-62. PubMed ID: 25093426
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide reduces nontransferrin-bound iron transport in HepG2 cells.
Barisani D; Cairo G; Ginelli E; Marozzi A; Conte D
Hepatology; 1999 Feb; 29(2):464-70. PubMed ID: 9918923
[TBL] [Abstract][Full Text] [Related]
12. High nontransferrin bound iron levels and heart disease in thalassemia major.
Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
[TBL] [Abstract][Full Text] [Related]
13. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.
Porter JB; Davis BA
Best Pract Res Clin Haematol; 2002 Jun; 15(2):329-68. PubMed ID: 12401311
[TBL] [Abstract][Full Text] [Related]
14. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron.
Matinaho S; Karhumäki P; Parkkinen J
Transfusion; 2005 Nov; 45(11):1768-73. PubMed ID: 16271102
[TBL] [Abstract][Full Text] [Related]
15. Iron metabolism and iron chelation in sickle cell disease.
Walter PB; Harmatz P; Vichinsky E
Acta Haematol; 2009; 122(2-3):174-83. PubMed ID: 19907155
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore.
Sharma M; Saxena R; Gohil NK
Anal Biochem; 2009 Nov; 394(2):186-91. PubMed ID: 19632191
[TBL] [Abstract][Full Text] [Related]
17. Non-transferrin-bound iron and tumor cells.
Anghileri LJ; Thouvenot P
Anticancer Res; 1997; 17(4A):2529-33. PubMed ID: 9252675
[TBL] [Abstract][Full Text] [Related]
18. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.
Breuer W; Ronson A; Slotki IN; Abramov A; Hershko C; Cabantchik ZI
Blood; 2000 May; 95(9):2975-82. PubMed ID: 10779448
[TBL] [Abstract][Full Text] [Related]
19. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
20. Non-transferrin bound iron measurement is influenced by chelator concentration.
Kolb AM; Smit NP; Lentz-Ljuboje R; Osanto S; van Pelt J
Anal Biochem; 2009 Feb; 385(1):13-9. PubMed ID: 19026979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
